Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8400243 | 0.72 | CHRM2 (0.36) | CHRM2CHRM3 | |
| SCHEMBL8400245 | 0.71 | CHRM2 (0.68) | CHRM2CHRM3 | |
| SCHEMBL8400773 | 0.66 | CHRM2 (0.36) | CHRM2CHRM3 | |
| SCHEMBL26774057 | 0.64 | AURKA (0.36) | — | |
| SCHEMBL9724673 | 0.61 | CHRM2 (0.50) | CHRM2CHRM3 | |
| SCHEMBL10589150 | 0.61 | CHRM2 (0.33) | CHRM2CHRM3 | |
| SCHEMBL25429146 | 0.60 | CHRNB4 (0.54) | — | |
| SCHEMBL30694707 | 0.60 | CHRNB4 (0.54) | — | |
| SCHEMBL30694702 | 0.60 | CHRNB4 (0.54) | — | |
| SCHEMBL10587700 | 0.60 | CHRM2 (0.35) | CHRM2CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE36374-E | 1,2,3-triazole and tetrazole substituted piperidine or tetrahydropyridine compounds useful as acetylcholine agonists | H. LUNDBECK, A/S (DK) | 1999-11-02 | — | — | US | disclosed |
| EP-0296721-B1 | HETEROCYCLIC COMPOUNDS | H. LUNDBECK A/S (DK) | 1993-06-23 | — | — | EP | disclosed |
| US-4925858-A | NERVOUS SYSTEM DISORDERS, ALZHEIMER*S DISEASE | H. LUNDBECK A/S (DK) | 1990-05-15 | — | — | US | disclosed |
| US-4866077-A | TREATMENT OF NERVOUS SYSTEM DISORDERS SUCH AS ALZHEIMER*S DISEASE | H. LUNDBECK A/S (DK) | 1989-09-12 | — | — | US | disclosed |
| EP-0296721-A2 | Heterocyclic compounds | H. LUNDBECK A/S (DK) | 1988-12-28 | — | — | EP | disclosed |